Free tool

Diagnostics stocks

We cover 8 companies grouped under the Diagnostics theme. The median market value in the group is $285.93M. Across the group, the median move over the past trading day is −0.19%. Price change over the past year runs from −40.6% to +242.9% across the middle 80 percent of the group, with a median of −17.3%. Across the group, 1 company currently carries a tier A volume signal.

Other lists in this group

Table

8 of 150 companies match these filters.Clear filters

TickerCompanyPrice1M returnYTD return1Y return
CAICaris Life Sciences, Inc.$26.82+72.03%−0.59%−29.83%
CDNACareDx, Inc.$50.96+42.55%+166.25%+283.45%
YDESYD Bio Ltd$4.34+88.70%−63.83%−63.83%
BDSXBiodesix, Inc.$30.60+45.51%+373.68%+225.53%
0RAR.LStratec SE22.90 EUR+2.00%+3.39%−14.98%
XGNExagen Inc.$7.67+72.36%+26.99%−19.69%
4671.TFALCO HOLDINGS Co., Ltd.2,892.00 JPY+4.82%+10.10%+21.78%
BVXP.LBioventix PLC1,750.00 GBP+15.89%−5.88%−30.64%

Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.

More ways to browse